JnJ Spravato gets USFDA nod as monotherapy for adults with treatment-resistant depression Ruchika Sharma22 Jan 2025 11:35 AM ISTTitusville: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application...
Alembic Pharma bags USFDA final approval for schizophrenia drug Brexpiprazole Ruchika Sharma15 Jan 2025 1:30 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
Depression may Increase Risky Driving Patterns Among Older Adults, reports JAMA study Dr Riya Dave31 Dec 2024 11:30 PM ISTAccording to researchers older adults with major depressive disorder (MDD) present with unique and riskier driving behaviors. A recent study was...
Patients with major depressive disorder may have significantly high Triglyceride levels and CVD risk: Study Jacinthlyn Sylvia27 Oct 2024 9:00 PM ISTA new study published in the journal of Public Library of Science found that the triglyceride levels of individuals with major depressive disorder...
Major depressive disorder increases risk of irritable bowel syndrome, reveals research Jacinthlyn Sylvia26 Sept 2024 8:45 PM ISTA new study published in the Journal of Affective Disorders demonstrated the causal relationships between major depressive disorder (MDD),...
Strides Pharma Science arm gets USFDA nod for Fluoxetine Tabs Ruchika Sharma16 Sept 2024 6:00 PM ISTFluoxetine is an antidepressant of the Selective Serotonin Reuptake Inhibitor class.
Perimenopause closely associated with increased mania and depression risk: Study Jacinthlyn Sylvia23 Aug 2024 8:15 PM ISTA new study published in the recent issue of Nature Mental Health journal found an increased risk of mania and major depressive disorder (MDD) in...
Study Reveals Potential Causal Link Between Depression and Peripheral Artery Disease Dr.Niharika Harsha B19 Aug 2024 8:15 PM ISTIn a recent innovative study, researchers have uncovered compelling evidence suggesting a potential causal relationship between Major Depressive...
Lumateperone as adjunct significantly reduces depression symptoms in patients with major depressive disorder phase 3 trial shows Dr. Kamal Kant Kohli24 Jun 2024 8:30 PM ISTIntra-Cellular Therapies, Inc, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system...
ACP finds only one of eight measures to be valid for management of major depressive disorder Medha Baranwal23 April 2024 9:30 PM ISTUSA: The American College of Physicians (ACP) has released a review of performance measures designed to evaluate the quality of care for those with...
Strides Pharma Science Singapore arm gets USFDA nod for Major Depressive Disorder drug Fluoxetine Ruchika Sharma9 April 2024 12:30 PM ISTThe product is bioequivalent and therapeutically equivalent to the Reference Listed Drug Prozac Tablets of Eli Lilly.
Combination of empagliflozin and citalopram effective against major depressive disorder: Study Medha Baranwal2 April 2024 4:00 AM ISTIran: Combination therapy of empagliflozin and citalopram is effective in reducing symptom severity in patients with major depressive disorder, a...
